Akhoondi, S., Lindström, L., Widschwendter, M., Corcoran, M., Bergh, J., Spruck, C., . . . Sangfelt, O. (2010). Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer. BioMed Central.
Citação norma ChicagoAkhoondi, Shahab, Linda Lindström, Martin Widschwendter, Martin Corcoran, Jonas Bergh, Charles Spruck, Dan Grandér, and Olle Sangfelt. Inactivation of FBXW7/hCDC4-β Expression By Promoter Hypermethylation Is Associated With Favorable Prognosis in Primary Breast Cancer. BioMed Central, 2010.
Citação norma MLAAkhoondi, Shahab, et al. Inactivation of FBXW7/hCDC4-β Expression By Promoter Hypermethylation Is Associated With Favorable Prognosis in Primary Breast Cancer. BioMed Central, 2010.